Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Clinical trial NCT00613509 · TERMINATED
Trial details
- NCT number
- NCT00613509
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2010-04-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.